ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
66 hedge funds and large institutions have $42M invested in Zynerba Pharmaceuticals, Inc in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more funds holding
Funds holding: 57 → 66 (+9)
Holders
66
Holding in Top 10
–
Calls
$4.74M
Puts
$2.74M
Top Buyers
| 1 | +$4.31M | |
| 2 | +$3.02M | |
| 3 | +$1.25M | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
+$1.06M |
| 5 |
BlackRock
New York
|
+$879K |
Top Sellers
| 1 | -$1.66M | |
| 2 | -$475K | |
| 3 | -$437K | |
| 4 |
SC
Sculptor Capital
New York
|
-$271K |
| 5 |
JP Morgan Chase
New York
|
-$249K |